Drug Type Antibody drug conjugate (ADC) |
Synonyms PBX 001, PBX001 |
Target |
Mechanism Trop-2 inhibitors(Tumor-associated calcium signal transducer 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | KR | 01 Nov 2024 | |
Bladder Cancer | Preclinical | KR | 07 Jun 2023 | |
Pancreatic Cancer | Preclinical | KR | 07 Jun 2023 | |
Triple Negative Breast Cancer | Preclinical | KR | 07 Jun 2023 |